NCT03000803View on ClinicalTrials.gov

Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2029

Conditions
Obesity
Interventions
BEHAVIORAL

Early Total Caloric Intake

Provide subjects a regimented amount of calories at each meal.

BEHAVIORAL

Late Total Caloric Intake

Provide subjects a regimented amount of calories at each meal.

All Listed Sponsors
lead

University of Chicago

OTHER

NCT03000803 - Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk | Biotech Hunter | Biotech Hunter